USP - Standards von der United States Pharmacopeia

(1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)

(2-Methyl-3,4,10,14b-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-1(2H)-one)

(2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one)

(1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine)

(This mixture contains mirtazapine, impurity A, impurity B, impurity C, impurity D, impurity E and impurity F)

(2,2-Bis(4-Chlorophenyl)-1,1-dichloroethane)

(Mixture of 0.2 mg 1-Amino-5,8-dihydroxy-4-({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione hydrochloride and 0.1 mg Mitoxantrone Hydrochloride)

(2-[(diphenylmethyl)sulfinyl]acetic acid)

(2-[(diphenylmethyl)sulfenyl]acetamide)

(30 mg

(3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)

(21-Chloro-16alpha-methyl-3,11,20-trioxopregna-1,4-dien-17-yl furan-2-carboxylate)